HemeTalks: Conversations in Hematology Education
by American Society of Hematology
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 21 chart positions in 21 markets.
By chart position
- 🇦🇺AU · Courses#9030K to 100K
- 🇩🇪DE · Courses#1115K to 30K
- 🇺🇸US · Courses#1465K to 30K
- 🇨🇦CA · Courses#1965K to 30K
- 🇯🇵JP · Courses#20100K to 300K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
94K to 324K🎙 ~2x weekly·32 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
188K to 648K🇯🇵46%🇦🇺15%🇩🇪5%+18 more - Active Followers
Loyal subscribers who consistently listen
56K to 194K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 17 epsHost
Recent guests
Recent episodes
Warm Autoimmune Hemolytic Anemia: The Patient Perspective
Jul 16, 2026
30m 45s
Warm Autoimmune Hemolytic Anemia: Challenges, Choices, and New Therapies
Jul 2, 2026
28m 10s
Unfolding Amyloid: A Patient Perspective
Jun 18, 2026
30m 43s
Re‑Thinking “Normal”: Absolute Neutrophil Count by Duffy Status
Jun 4, 2026
20m 51s
Multiple Myeloma Care: Timing, Teamwork, Treatment
May 21, 2026
23m 00s
Social Links & Contact
Official channels & resources
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/16/26 | patient advocacyautoimmune disorders+4 | Mr. Sean Powell | prednisonerituximab+2 | — | warm autoimmune hemolytic anemiapatient advocacy+5 | — | 30m 45s | ||
| 7/2/26 | warm autoimmune hemolytic anemiadiagnosis+3 | Allyson Pishko, MD, MSCE | University of Pennsylvania | — | warm autoimmune hemolytic anemiadiagnosis+5 | Johnson & Johnson | 28m 10s | ||
| 6/18/26 | AL amyloidosispatient advocacy+3 | Dr. Sai Jambunathan | American Society of HematologyNew Jersey | — | AL amyloidosispatient experience+5 | — | 30m 43s | ||
| 6/4/26 | Absolute Neutrophil CountDuffy Status+4 | Dr. Maureen AchebeDr. Lauren Merz | American Society of Hematology | — | Absolute Neutrophil CountDuffy null variant+5 | — | 20m 51s | ||
| 5/21/26 | multiple myelomatreatment strategies+5 | Dr. DevarakondaKathy Giusti | Multiple Myeloma Research Foundation | — | multiple myelomatreatment+5 | — | 23m 00s | ||
| 5/21/26 | mieloma múltipletratamiento+3 | Dr. DevarakondaKathy Giusti | Multiple Myeloma Research Foundation | — | mieloma múltipletratamiento+4 | — | 22m 01s | ||
| 5/7/26 | TTPhematologic emergency+5 | Dr. Yazan Abou-IsmailDr. Kolton Smith | caplacizumabAmerican Society of Hematology+1 | — | TTPdiagnosis+7 | — | 19m 56s | ||
| 4/16/26 | myelodysplastic neoplasmsdiagnostics+4 | Dr. DeZernDr. Mack | American Society of Hematologymyelodysplastic neoplasms+1 | — | MDSdiagnosis+6 | — | 25m 27s | ||
| 3/19/26 | smoldering multiple myelomatreatment landscape+3 | Brea LipeSagar Lonial | American Society of Hematology | United States | smoldering multiple myelomaMGUS+4 | — | 26m 19s | ||
| 2/19/26 | MGUSserum protein electrophoresis+3 | Rahma WarsameJason Chen | American Society of HematologyInterpreting Abnormal SPEP – Is It Just MGUS? | — | MGUSserum monoclonal protein+3 | — | 27m 10s | ||
| 1/15/26 | thrombophilia testingVTE management+3 | Ronak MistryJori May | American Society of Hematology | — | thrombophiliaVTE+3 | — | 28m 03s | ||
| 12/18/25 | aHUSpatient advocacy+3 | Dr. Toyosi Onwuemene | aHUS FoundationAmerican Society of Hematology | — | aHUShemolytic uremic syndrome+5 | — | 20m 15s | ||
| 11/20/25 | Duffy null phenotypeabsolute neutrophil count+4 | Dr. Andrew HintelDr. Lauren Merz | American Society of HematologyDoris Duke Foundation | — | Duffy-nullneutrophil count+4 | — | 25m 50s | ||
| 10/16/25 | thalassemiapediatric hematology+4 | Sujit ShethAshutosh Lal | American Society of Hematologybeta-thalassemia major | MediterraneanMiddle East+2 | thalassemiapediatric+6 | — | 19m 21s | ||
| 9/18/25 | CAR-T therapycare coordination+4 | Dr. CaimiDr. Sdrimas | American Society of Hematology | — | CAR-Tpatient care+6 | — | 20m 00s | ||
| 8/21/25 | relapsed myelomaBCMA therapy failure+4 | Dr. Natalia NeparidzeDr. Saad Z. Usmani | CAR T-cell therapybispecific antibodies+2 | BCMAmultiple myeloma | relapsed myelomaBCMA-targeted therapy+4 | — | 22m 46s | ||
| 7/17/25 | hereditary hemorrhagic telangiectasiadiagnosis+4 | Hanny Al-SamkariAdrienne Hammill | American Society of Hematology | — | HHTtelangiectasia+5 | — | 22m 38s |
Showing 17 of 17
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for HemeTalks: Conversations in Hematology Education
Peaked at #20 in Japan, currently #20 in Japan.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Japan | — | #20 | #20 | — |
| IS | — | #29 | #29 | — |
| TW | — | #47 | #47 | — |
| New Zealand | — | #69 | #69 | — |
| Finland | — | #71 | #71 | — |
| SG | — | #75 | #75 | — |
| TR | — | #88 | #88 | — |
| NG | — | #89 | #89 | — |
| Australia | — | #90 | #90 | — |
| SA | — | #97 | #97 | — |
| Sweden | — | #108 | #108 | — |
| Germany | — | #111 | #111 | — |
| India | — | #119 | #119 | — |
| AR | — | #128 | #128 | — |
| MY | — | #129 | #129 | — |
| United States | — | #146 | #146 | — |
| Ireland | — | #149 | #149 | — |
| AT | — | #149 | #149 | — |
| AE | — | #191 | #191 | — |
| Canada | — | #196 | #196 | — |
Chart Positions
21 placements across 21 markets.
Chart Positions
21 placements across 21 markets.